Audrey Taieb
Overview
Explore the profile of Audrey Taieb including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
188
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Charpentier C, Visseaux B, Benard A, Peytavin G, Damond F, Roy C, et al.
AIDS
. 2013 Apr;
27(10):1671-4.
PMID: 23595155
We report the first transmitted drug resistance survey study in HIV-2-infected patients living in France. The prevalence of transmitted drug resistance was 5.0% (95% confidence interval, 0.1-9.9) with mutations detected...
2.
Visseaux B, Charpentier C, Taieb A, Damond F, Benard A, Larrouy L, et al.
AIDS
. 2012 Oct;
27(2):292-5.
PMID: 23095312
In this study, assessing HIV-2 tropism among 43 paired plasma/peripheral blood mononuclear cell specimens, the concordance between proviral DNA and plasma RNA genotypic tropism prediction was 74%. All the discordances...
3.
Thiebaut R, Charpentier C, Damond F, Taieb A, Antoine R, Capeau J, et al.
Clin Infect Dis
. 2012 Aug;
55(10):1417-25.
PMID: 22911639
Background: Human immunodeficiency virus type 2 (HIV-2) infection is characterized by a slower progression than HIV type 1. It is not known whether markers of inflammation such as high-sensitivity C-reactive...
4.
Nazih H, Raffi F, Taieb A, Reynes J, Choutet P, Cassuto J, et al.
AIDS Res Hum Retroviruses
. 2011 Sep;
28(4):393-9.
PMID: 21877956
Highly active antiretroviral therapy (HAART) is associated with fat redistribution and metabolic disorders. The present study was undertaken to evaluate the association between peroxisome proliferator activated receptor (PPAR)α and PPARγ...
5.
Damond F, Benard A, Balotta C, Boni J, Cotten M, Duque V, et al.
J Clin Microbiol
. 2011 Aug;
49(10):3491-7.
PMID: 21813718
Accurate HIV-2 plasma viral load quantification is crucial for adequate HIV-2 patient management and for the proper conduct of clinical trials and international cohort collaborations. This study compared the homogeneity...
6.
Masquelier B, Taieb A, Reigadas S, Marchou B, Cheneau C, Spire B, et al.
J Antimicrob Chemother
. 2011 Apr;
66(7):1582-9.
PMID: 21525020
Background: The aim of our study was to determine whether HIV-1 DNA level before antiretroviral therapy (ART) was associated with short- and long-term virological and immunological responses. Methods: Patients starting...
7.
Benard A, van Sighem A, Taieb A, Valadas E, Ruelle J, Soriano V, et al.
Clin Infect Dis
. 2011 Apr;
52(10):1257-66.
PMID: 21507923
Background: Triple nucleoside reverse-transcriptase inhibitors (NRTIs) are recommended by the World Health Organization as first-line regimen in treatment-naïve HIV-2-infected patients. However, ritonavir-boosted protease inhibitor (PI/r)-containing regimens are frequently prescribed. In...
8.
Thiebaut R, Matheron S, Taieb A, Brun-Vezinet F, Chene G, Autran B
AIDS
. 2011 Mar;
25(6):865-7.
PMID: 21358376
Among 342 HIV-2-infected patients of the ANRS CO5 HIV-2 cohort, the prevalence of long-term nonprogressors (LTNPs) (i.e. asymptomatic for at least 8 years while maintaining CD4 cell count at least...
9.
Benard A, Damond F, Campa P, Peytavin G, Descamps D, Lascoux-Combes C, et al.
AIDS
. 2009 Apr;
23(9):1171-3.
PMID: 19349850
In 29 antiretroviral-naive HIV-2-infected patients starting lopinavir/ritonavir-containing regimen, the median CD4 cell count change from baseline (142 cells/microl) was +71 cells/microl at week 24 and +132 cells/microl at week 96....
10.
Preau M, Leport C, Villes V, Michelet C, Collin F, Carrieri M, et al.
J Acquir Immune Defic Syndr
. 2008 Apr;
47(4):467-71.
PMID: 18434958
Objectives: We studied the evolution of the patient-provider relationship (PPR) in HIV-infected patients who reported trustful relationships at highly active antiretroviral therapy (HAART) treatment initiation. Methods: Psychosocial and clinical data...